Intrommune Therapeutics, Inc. announced it raised $68,000 in an amended filing from an offering of $20 Million

Jul 08, 2021•about 4 years ago

Amount Raised

$68,000

Round Type

pre-seed

New YorkHealth CareBiotechnology

Company Information

Company

Intrommune Therapeutics, Inc.

Location

20 W 125TH ST. UNIT #1

New York, New York, United States

About

Intrommune Therapeutics is a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Intrommune Therapeutics, Inc. announced it raised $68,000 in an amended filing from an offering of $20 Million

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information